Tesamorelin (20ml)
$139.00
A synthetic stabilized GHRH analog studied in laboratory research for its effects on growth hormone secretion and lipid metabolism biology.
Buy 1
SAVE 0%
Buy 3
SAVE 20%
Buy 5
SAVE 33%
Buy 7+
SAVE 50%
Description
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) in which the full GHRH(1–44) sequence is conjugated to a trans-3-hexenoic acid moiety, significantly enhancing its stability relative to native GHRH. It has been studied in research and clinical settings, most notably in the context of HIV-associated lipodystrophy, where it received FDA approval (as Egrifta) for the reduction of excess abdominal fat in affected adults.
Laboratory research has investigated Tesamorelin’s interactions with the somatotropic axis, its comparative pharmacokinetic profile relative to other GHRH analogs, and its effects on visceral adipose tissue biology and metabolic signaling in preclinical models. The availability of clinical trial data provides a particularly well-characterized scientific foundation for laboratory investigation.
Supplied as a lyophilized Research Use Only (RUO) material, analytically verified for identity and purity with batch-specific Certificate of Analysis documentation
